[x] 1. [@Zimmerli2006] Zimmerli W. Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. Best practice & research Clinical rheumatology 2006;20(6):1045-63. doi: 10.1016/j.berh.2006.08.003 [published Online First: 2006/11/28]
[x] 3. Shohat N, Bauer T, Buttaro M, et al. Hip and Knee Section, What is the Definition of a Periprosthetic Joint Infection (PJI) of the Knee and the Hip? Can the Same Criteria be Used for Both Joints?: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty 2019;34(2s):S325-s27. doi: 10.1016/j.arth.2018.09.045 [published Online First: 2018/10/23]
[x] 4. Ridgeway S, Wilson J, Charlet A, et al. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005;87(6):844-50. doi: 10.1302/0301-620x.87b6.15121 [published Online First: 2005/05/25]
[x] 5. Lai K, Bohm ER, Burnell C, et al. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty 2007;22(5):651-6. doi: 10.1016/j.arth.2006.09.002 [published Online First: 2007/08/11]
[x] 6. Malinzak RA, Ritter MA, Berend ME, et al. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 2009;24(6 Suppl):84-8. doi: 10.1016/j.arth.2009.05.016 [published Online First: 2009/07/17]
[x] 7. Ong KL, Kurtz SM, Lau E, et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009;24(6 Suppl):105-9. doi: 10.1016/j.arth.2009.04.027 [published Online First: 2009/06/06]
[x] 8. Pedersen AB, Mehnert F, Johnsen SP, et al. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br 2010;92(7):929-34. doi: 10.1302/0301-620x.92b7.24461 [published Online First: 2010/07/03]
[x] 9. Bozic KJ, Lau E, Kurtz S, et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 2012;94(9):794-800. doi: 10.2106/jbjs.k.00072 [published Online First: 2012/05/04]
[x] 10. Jamsen E, Nevalainen P, Eskelinen A, et al. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 2012;94(14):e101. doi: 10.2106/jbjs.j.01935 [published Online First: 2012/07/20]
[x] 11. [@Rasouli2014a] Rasouli MR, Restrepo C, Maltenfort MG, et al. Risk factors for surgical site infection following total joint arthroplasty. J Bone Joint Surg Am 2014;96(18):e158. doi: 10.2106/jbjs.m.01363 [published Online First: 2014/09/19]
[x] 12. Maoz G, Phillips M, Bosco J, et al. The Otto Aufranc Award: Modifiable versus Nonmodifiable Risk Factors for Infection After Hip Arthroplasty. Clin Orthop Relat Res 2014 doi: 10.1007/s11999-014-3780-x [published Online First: 2014/07/16]
[x] 13. Haynes SR, Lawler PG. An assessment of the consistency of ASA physical status classification allocation. Anaesthesia 1995;50(3):195-9. [published Online First: 1995/03/01]
[x] 14. Berbari EF, Osmon DR, Lahr B, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2012;33(8):774-81. doi: 10.1086/666641 [published Online First: 2012/07/05]
[x] 15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8 [published Online First: 1987/01/01]
[x] 16. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. American journal of epidemiology 2011;173(6):676-82. doi: 10.1093/aje/kwq433 [published Online First: 2011/02/19]
[x] 17. Edelstein AI, Kwasny MJ, Suleiman LI, et al. Can the American College of Surgeons Risk Calculator Predict 30-Day Complications After Knee and Hip Arthroplasty? J Arthroplasty 2015;30(9 Suppl):5-10. doi: 10.1016/j.arth.2015.01.057 [published Online First: 2015/07/15]
[x] 18. Wingert NC, Gotoff J, Parrilla E, et al. The ACS NSQIP Risk Calculator Is a Fair Predictor of Acute Periprosthetic Joint Infection. Clin Orthop Relat Res 2016;474(7):1643-8. doi: 10.1007/s11999-016-4717-3 [published Online First: 2016/02/26]
[x] 19. [@Bozic2013a] Bozic KJ, Ong K, Lau E, et al. Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res 2013;471(2):574-83. doi: 10.1007/s11999-012-2605-z [published Online First: 2012/11/28]
[x] 20. [@Inacio2015a] Inacio MC, Pratt NL, Roughead EE, et al. Predicting Infections After Total Joint Arthroplasty Using a Prescription Based Comorbidity Measure. J Arthroplasty 2015;30(10):1692-8. doi: 10.1016/j.arth.2015.05.004 [published Online First: 2015/05/20]
[x] 22. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC public health 2011;11:450. doi: 10.1186/1471-2458-11-450 [published Online First: 2011/06/11]
[x] 23. [@Pedersen2010a] Pedersen AB, Svendsson JE, Johnsen SP, et al. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop 2010;81(5):542-7. doi: 10.3109/17453674.2010.519908 [published Online First: 2010/09/24]
[x] 24. Dale H, Fenstad AM, Hallan G, et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012;83(5):449-58. doi: 10.3109/17453674.2012.733918 [published Online First: 2012/10/23]
[x] 25. Sayed-Noor AS, Mukka S, Mohaddes M, et al. Body mass index is associated with risk of reoperation and revision after primary total hip arthroplasty: a study of the Swedish Hip Arthroplasty Register including 83,146 patients. Acta Orthop 2019;90(3):220-25. doi: 10.1080/17453674.2019.1594015 [published Online First: 2019/04/02]
[x] 26. Everhart JS, Altneu E, Calhoun JH. Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin Orthop Relat Res 2013;471(10):3112-9. doi: 10.1007/s11999-013-2923-9 [published Online First: 2013/03/23]
[ ] 27. Tan TL, Maltenfort MG, Chen AF, et al. Development and Evaluation of a Preoperative Risk Calculator for Periprosthetic Joint Infection Following Total Joint Arthroplasty. J Bone Joint Surg Am 2018;100(9):777-85. doi: 10.2106/jbjs.16.01435 [published Online First: 2018/05/02]
[ ] 28. Poultsides LA, Ma Y, Della Valle AG, et al. In-hospital surgical site infections after primary hip and knee arthroplasty--incidence and risk factors. J Arthroplasty 2013;28(3):385-9. doi: 10.1016/j.arth.2012.06.027 [published Online First: 2012/11/13]
[ ] 29. Pulido L, Ghanem E, Joshi A, et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008;466(7):1710-5. doi: 10.1007/s11999-008-0209-4 [published Online First: 2008/04/19]
[ ] 30. Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br 2012;94(10):1330-8. doi: 10.1302/0301-620x.94b10.29184 [published Online First: 2012/09/28]
[ ] 31. Higuera CA, Elsharkawy K, Klika AK, et al. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res 2011;469(5):1391-400. doi: 10.1007/s11999-011-1804-3 [published Online First: 2011/02/25]
[ ] 32. Inacio MC, Pratt NL, Roughead EE, et al. Using Medications for Prediction of Revision after Total Joint Arthroplasty. J Arthroplasty 2015;30(12):2061-70. doi: 10.1016/j.arth.2015.06.009 [published Online First: 2015/07/21]
[ ] 33. Mraovic B, Suh D, Jacovides C, et al. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. Journal of diabetes science and technology 2011;5(2):412-8. [published Online First: 2011/04/30]
[ ] 34. Iorio R, Williams KM, Marcantonio AJ, et al. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty 2012;27(5):726-9 e1. doi: 10.1016/j.arth.2011.09.013 [published Online First: 2011/11/08]
[ ] 35. Gilson M, Gossec L, Mariette X, et al. Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor alpha-blockers: a case-control study. Arthritis research & therapy 2010;12(4):R145. doi: 10.1186/ar3087 [published Online First: 2010/07/20]
[ ] 36. Momohara S, Kawakami K, Iwamoto T, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Modern rheumatology / the Japan Rheumatism Association 2011;21(5):469-75. doi: 10.1007/s10165-011-0423-x [published Online First: 2011/02/15]
[ ] 37. Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br 2010;92(8):1128-33. doi: 10.1302/0301-620x.92b8.24333 [published Online First: 2010/08/03]
[ ] 38. Cancienne JM, Werner BC, Luetkemeyer LM, et al. Does Timing of Previous Intra-Articular Steroid Injection Affect the Post-Operative Rate of Infection in Total Knee Arthroplasty? J Arthroplasty 2015;30(11):1879-82. doi: 10.1016/j.arth.2015.05.027 [published Online First: 2015/06/14]